Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Monday, December 01, 2014 8:55:52 AM
bullish
gap up
$ISR recent news/filings
## source: finance.yahoo.com
Mon, 01 Dec 2014 13:15:00 GMT ~ IsoRay's Cesium-131 Therapy Stops Brain Cancers from Recurring in Treated Locations Where Previous Conventional Treatments Failed
[Accesswire] - World-Renowned Barrow Neurological Institute Releases Dramatic Brain Study Findings RICHLAND, WA / ACCESSWIRE / December 1, 2014 / IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator ...
read full: http://finance.yahoo.com/news/isorays-cesium-131-therapy-stops-131500290.html
*********************************************************
Fri, 21 Nov 2014 18:04:33 GMT ~ ISORAY, INC. Financials
read full: http://finance.yahoo.com/q/is?s=isr
*********************************************************
Tue, 18 Nov 2014 18:09:05 GMT ~ IsoRay, Inc. Reports First Quarter Results
[at noodls] - 7% Revenue Growth In Prostate Cancer Cases Quarter Over Quarter RICHLAND, Washington (November 17, 2014) - IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy ...
read full: http://www.noodls.com/view/0DB6BF125F33594ABE02792BBA3DBBA8A7E9FED9
*********************************************************
Mon, 17 Nov 2014 13:46:04 GMT ~ ISORAY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/141117/isr8-k.html
*********************************************************
Mon, 17 Nov 2014 13:00:00 GMT ~ IsoRay, Inc. Reports First Quarter Results
[Accesswire] - 7% Revenue Growth in Prostate Cancer Cases Quarter over Quarter RICHLAND, WA / ACCESSWIRE / November 17, 2014 / IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy ...
read full: http://finance.yahoo.com/news/isoray-inc-reports-first-quarter-130000298.html
*********************************************************
$ISR charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ISR company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ISR/company-info
Ticker: $ISR
OTC Market Place: Not Available
CIK code: 0000728387
Company name: IsoRay, Inc.
Company website: http://www.isoray.com
Incorporated In: MN, USA
$ISR share structure
## source: otcmarkets.com
Market Value: $88,911,181 a/o Nov 28, 2014
Shares Outstanding: 54,883,445 a/o Sep 26, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$ISR extra dd links
Company name: IsoRay, Inc.
Company website: http://www.isoray.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ISR/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ISR/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ISR+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ISR+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ISR+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ISR/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ISR/news - http://finance.yahoo.com/q/h?s=ISR+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ISR/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ISR/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ISR/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ISR/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ISR/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ISR/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ISR/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ISR/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ISR+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ISR
DTCC (dtcc.com): http://search2.dtcc.com/?q=IsoRay%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=IsoRay%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=IsoRay%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.isoray.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.isoray.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.isoray.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ISR/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ISR
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ISR/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ISR/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ISR/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000728387&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ISR/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ISR/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ISR/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ISR/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ISR&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ISR
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ISR/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ISR+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ISR+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ISR
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ISR
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ISR+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ISR/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ISR+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ISR.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ISR
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ISR/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ISR/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ISR/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ISR/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ISR
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ISR
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ISR:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ISR
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ISR
$ISR DD Notes ~ http://www.ddnotesmaker.com/ISR
Recent CATX News
- Perspective Therapeutics Presents at the World Molecular Imaging Congress 2024 • GlobeNewswire Inc. • 09/10/2024 11:00:00 AM
- Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive Melanoma • GlobeNewswire Inc. • 09/05/2024 11:00:00 AM
- Perspective Therapeutics to Participate in Upcoming Investor Conferences in September • GlobeNewswire Inc. • 08/28/2024 11:00:00 AM
- Rumble Shares Up 7% in Premarket After 27% Q2 Revenue Surge; More on Earnings • IH Market News • 08/13/2024 09:39:29 AM
- Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 2Q 2024 Results • GlobeNewswire Inc. • 08/12/2024 08:05:59 PM
- U.S. Futures Steady as Markets Await Key Inflation Data, Oil Prices Climb • IH Market News • 08/12/2024 09:47:41 AM
- Perspective Therapeutics to Participate at Upcoming Investor Conferences in August • GlobeNewswire Inc. • 07/30/2024 11:00:00 AM
- Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/22/2024 11:00:00 AM
- Perspective Therapeutics Announces Inclusion in the Russell 3000® Index • GlobeNewswire Inc. • 06/12/2024 11:00:00 AM
- Perspective Therapeutics Announces 1-for-10 Reverse Stock Split • GlobeNewswire Inc. • 06/11/2024 11:00:00 AM
- Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting • GlobeNewswire Inc. • 06/10/2024 08:10:00 PM
- Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 05/24/2024 12:01:41 PM
- Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024 • GlobeNewswire Inc. • 05/20/2024 11:00:03 AM
- Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results • GlobeNewswire Inc. • 05/15/2024 11:00:00 AM
- Perspective Therapeutics to Participate at Upcoming May Investor Conferences • GlobeNewswire Inc. • 05/03/2024 11:00:00 AM
- Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs • GlobeNewswire Inc. • 04/30/2024 11:00:00 AM
- Perspective Therapeutics to Participate at Upcoming April Investor Conferences • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 03/28/2024 11:30:08 AM
- Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024 • GlobeNewswire Inc. • 03/11/2024 12:00:00 PM
- Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- Perspective Therapeutics Announces $87.4 Million Private Placement • GlobeNewswire Inc. • 03/04/2024 02:45:00 PM
- Perspective Therapeutics to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Perspective Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/12/2024 01:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM